Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis

Autoři	LUEBKE Johannes SCHWAAB Juliana CHRISTEN Deborah ELBERINK Hanneke Oude SPAN Bart NIEDOSZYTKO Marek GORSKA Aleksandra LANGE Magdalena GLEIXNER Karoline V HADZIJUSUFOVIC Emir SOLOMIANYI Oleksii ANGELOVA-FISCHER Irena ZANOTTI Roberta BONIFACIO Massimiliano BONADONNA Patrizia SHOUMARIYEH Khalid NIKOLAS von Bubnoff MUELLER Sabine PERKINS Cecelia ELENA Chiara MALCOVATI Luca HAGGLUND Hans MATTSSON Mattias PARENTE Roberta VARKONYI Judit FORTINA Anna Belloni CAROPPO Francesca ZINK Alexander BROCKOW Knut BREYNAERT Christine BULLENS Dominique YAVUZ Akif Selim DOUBEK Michael SABATO Vito SCHUG Tanja NIEDERWIESER Dietger HARTMANN Karin TRIGGIANI Massimo GOTLIB Jason HERMINE Olivier AROCK Michel KLUIN-NELEMANS Hanneke C PANSE Jens SPERR Wolfgang R VALENT Peter REITER Andreas JAWHAR Mohamad
Rok publikování	2023
Druh	Článek v odborném periodiku
Časopis / Zdroj	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://www.sciencedirect.com/science/article/abs/pii/S2213219822011977?via%3Dihub
Doi	http://dx.doi.org/10.1016/j.jaip.2022.10.051
Klíčová slova	Mastocytosis; Systemic mastocytosis; Organomegaly; Splenomegaly; Hepatomegaly; Lymphadenopathy
Popis	BACKGROUND: Organomegaly, including splenomegaly, hepatomegaly, and/or lymphadenopathy, are important diagnostic and prognostic features in patients with cutaneous mastocytosis (CM) or systemic mastocytosis (SM).